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Low birth weight is associated with insulin resistance and
type 2 diabetes in adults. The fetal programming hypothesis
has shown that insulin resistance and its associated metabolic
disturbances result from a poor gestational environment, for
which low birth weight is a surrogate. An at-home question-
naire survey was performed on 660 middle school students
(12-15 years) in Seoul, Korea, and 152 cases were randomly
selected based on their birth weight. Subjects were divided into
three groups according to birth weight. We recorded their birth
weight and measured their current anthropometric data, blood
pressure, lipid profile, HOMA-IR, and HOMA- , and com β -
pared these parameters among the groups. The relation of birth
weight to physiological characteristics in adolescence was
examined. Systolic blood pressure, lipid profiles, and fasting
plasma glucose, HOMA- were not significantly different β
among the groups, but diastolic blood pressure was lower in
the third tertile. Insulin, C-peptide, and HOMA-IR were higher
in the lower birth weight tertile. After adjustment for con-
founding factors, birth weight was inversely related to diastolic
blood pressure, insulin, C-peptide, and HOMA-IR. We con-
clude that low birth weight may predict the risk of the insulin
resistance and its progression over age, and that adequate
gestational nutrition is therefore necessary to prevent low birth
weight.
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INTRODUCTION
Epidemiological studies have demonstrated
that adults with a low birth weight are at an
increased risk of developing type 2 diabetes
mellitus (T2DM), which led to the hypothesis
that metabolic syndrome may be closely asso-
ciated with fetal nutritional state.
1 Hales et al.
proposed the thrifty phenotype hypothesis as a
cause of T2DM, by arguing that malnutrition
during the fetal and neonatal periods impairs
the development of endocrine function in the
pancreas, resulting in an impairment of insulin
secretion by -cells. β
2,3 In addition, Barker et al.
4
reported a higher death rate due to ischemic
cardiac disease in a study of 5,654 men with low
weight at birth and at 1 year of age. Such results
suggest that poor nutrition during the fetal
period may cause permanent structural and
functional changes in the pancreas that may
cause diabetes, hypertension, dyslipidemia, in-
sulin resistance, and other metabolic impair-
ments.
1,4
In most studies on birth weight and insulin
resistance, low birth weight infants show in-
creased insulin resistance as adolescences or
adults.
5 However, studies on the relationship
between birth weight and insulin resistance are
very rare in Korea.
6 Accordingly, the purpose
of our study is to examine whether birth
weight is related to insulin resistance, and to
determine whether fetal programming perma-
nently affects insulin resistance in Korean ado-
lescents.
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MATERIALS AND METHODS
Subjects
In April 2003, an at-home questionnaire survey
was administered to 660 middle school students
(12-15 years old) in Seoul, Korea, and 152 cases
were selected randomly based on their birth
weight. Birth weight data was based on birth
records, except in 21 cases (maternal recall) where
birth weight was not available from the birth
records. Tanner staging was completed during a
complete physical examination by a pediatrician.
Subjects were divided into three groups ac-
cording to birth weight. The subjects born prema-
turely, earlier than 37 weeks gestation, and those
with family history of diabetes (diabetes in either
parent) were excluded from the study. The study
protocol was approved by the Yonsei University
College of Medicine Ethical Committee, and in-
formed consent was obtained from each partici-
pant.
Methods
Physical measurements
Body weight and height were measured in the
morning, with participants wearing light clothing.
Body mass index (BMI) was calculated as body
weight divided by height (kg/m
2). Waist circum-
ference was determined using a measuring tape
placed midway between the lowest rib and the
iliac crest, with the participant standing on a flat
floor with his or her feet 30 cm apart. Body fat
percentage was evaluated by dual-energy X-ray
absorptiometry (Hologic QDR 1500; Delphi, Wal-
tham, MA, USA).
Blood pressure (mmHg) was measured twice
after the subject had been resting in the supine
position for 5 min with the use of an appropriate
cuff size in relation to arm size. Diastolic blood
pressure was determined as Korotkoff phase V.
The mean of the two measurements was used in
further analyses.
Blood collection and serological testing
Participants fasted from 10 PM to 9 AM, at
which time blood samples were collected. Plasma
glucose levels were measured immediately with
an autoanalyzer using the hexokinase method
(Hitachi 747; Roche, Montclair, NJ, USA). Serum
insulin and C-peptide levels were determined
using an enzyme chemiluminescence immuno-
assay (ECIA, DPC, Immulite DPC, Los Angeles,
USA). Serum total cholesterol and HDL-cho-
lesterol were measured using a direct enzymatic
method (Hitachi 747; Daiichi, Tokyo, Japan).
Serum triglyceride levels were measured by an
enzymatic colorimetric method (Hitachi 747;
Roche, Almere, Japan/Germany), and LDL-cho-
lesterol was calculated using the Friedewald
equation.
7
Measurement of insulin resistance and insulin secre-
tion
Insulin resistance was estimated after fasting
using the homeostasis model assessment method
for insulin resistance (HOMA-IR), and the ability
to secrete insulin was measured using a homeo-
stasis model assessment of -cell function β (HOMA-
). These models were originally developed by β
Matthews, subsequently modified,
8,9 and have
been validated in patients with T2DM and obe-
sity.
10,11 The formulas are as follows: HOMA-IR =
fasting insulin ( U/mL) μ × fasting plasma glucose
(mmol/L)/22.5; HOMA-β = 20 × fasting insulin (μ
U/ml)/[fasting plasma glucose (mmol/L)-3.5].
Statistical analysis
Descriptive statistics are presented as mean
values ± SD. We used an independent sample t-
test or Chi-square test for the comparison of males
and females, as appropriate. An ANOVA was per-
formed to compare birth weight, current age,
weight, height, BMI, waist circumference, and
body fat percentage of each group according to
their birth weight. The physiological character-
istics (systolic blood pressure, diastolic blood
pressure, total cholesterol, triglyceride, HDL-chol-
esterol, LDL-cholesterol, fasting plasma glucose,
insulin, C-peptide, HOMA-IR, and HOMA- ) β
were adjusted using a general linear model; the
covariates used were age, sex, height, weight,
waist circumference, body fat percentage, and
Tanner stage. The inclusion of covariates in the
general linear model removes its contribution to
the outcome variables. The relation of birth
weight to physiological characteristics in adoles-The Relation between Birth Weight and Insulin Resistance in Korean Adolescents
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cents was examined by partial correlation and
adjusted for age, sex, height, weight, waist cir-
cumference, body fat percentage, and Tanner
stage. Statistical analyses were conducted using
SPSS for Windows, version 11.0 (SPSS Inc.,
Chicago, IL, USA), and p < 0.05 was set as the
level of significance.
RESULTS
Physical measurements and the clinical charac-
teristics of the study subjects
Eighty subjects were male and seventy-two
were female, with an average age of 13.18 ± 0.92
years. No statistically significant difference in age
between genders was noted. Although height,
weight, and waist circumference were greater in
males compared to females, there was no dif-
ference in BMI. Body fat percentage was higher in
females. Blood pressure, fasting plasma glucose,
insulin, C-peptide, HOMA-IR, and HOMA- were β
not significantly different between males and
females. On the other hand, total cholesterol and
HDL-cholesterol levels were higher in females
(both p < 0.01), but triglyceride and LDL-cho-
lesterol levels were not significantly different
(Table 1).
Subjects were grouped into thirds according to
Table 1. Clinical Characteristics of Subjects
Male (n = 80) Female (n = 72) All (n = 152)
Birth weight (kg) 3.46 ± 0.67 3.22 ± 0.53* 3.34 ± 0.62
Age (year) 13.14 ± 0.88 13.24 ± 0.93 13.18 ± 0.92
Weight (kg) 55.67 ± 13.55 51.84 ± 9.44* 53.86 ± 11.90
Height (cm) 161.65 ± 8.94 157.15 ± 4.45 159.52 ± 7.50
BMI (kg/m
2) 21.15 ± 4.21 20.93 ± 3.42 21.04 ± 3.85
Waist circumference (cm) 73.83 ± 9.97 68.30 ± 6.33 71.21 ± 8.86
Body fat percentage (%) 11.34 ± 7.69 25.27 ± 7.62 17.94 ± 10.34
Tanner stage 3.48 ± 0.63 3.75 ± 0.62 3.61 ± 0.64
SBP (mmHg) 117.09 ± 13.48 114.06 ± 11.72 115.65 ± 12.72
DBP (mmHg) 73.63 ± 10.45 73.68 ± 9.26 73.65 ± 9.87
Total cholesterol (mmol/L) 4.232 ± 0.711 4.557 ± 0.654 4.386 ± 0.701
Triglycerides (mmol/L) 0.824 ± 0.301 0.913 ± 0.354 0.866 ± 0.329
HDL-C (mmol/L) 1.157 ± 0.222 1.266 ± 0.211 1.209 ± 0.223
LDL-C (mmol/L) 2.696 ± 0.630 2.872 ± 0.562 2.779 ± 0.604
FPG (mmol/L) 5.405 ± 0.497 5.319 ± 0.479 5.365 ± 0.489
Insulin (pmol/L) 68.9 ± 48.3 75.3 ± 46.2 71.93 ± 47.11
C-peptide ( g/L) μ 1.84 ± 0.60 1.94 ± 0.48 1.89 ± 0.55
HOMA-IR 1.68 ± 1.23 1.80 ± 1.15 1.74 ± 1.19
HOMA-β 76.07 ± 58.36 90.05 ± 73.34 82.69 ± 66.02
Values are mean ± SD.
*p < 0.05 vs. male, p < 0.01 vs. male, p < 0.001 vs. male.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C,
HDL-cholesterol, LDL-C, LDL-cholesterol; FPG, fasting plasma glucose; HOMA-IR, Homeostasis model assessment for insulin
resistance; HOMA- , Homeostasis model assessment for -cell function. β βChul-Sik Kim, et al.
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birth weight. Analysis of grouped data from
males and females showed that birth weight cor-
related with adolescent body size. Current weight,
height, BMI, waist circumference, body fat per-
centage, and Tanner stage all increased with birth
weight tertile. Systolic blood pressure, lipid pro-
files, fasting plasma glucose, and HOMA- were β
not significantly different between groups, but
diastolic blood pressure was lower in the third
tertile. Lower birth weight was related to insulin
resistance in adolescence and insulin, C-peptide,
and HOMA-IR were higher in the lower birth
weight tertile (all p < 0.05) (Table 2).
Association of birth weight with physiological
characteristics in adolescence
There was no significant relationship between
Table 2. Anthropometric and Physiological Characteristics according to Thirds of Birth Weight
Birth weight (tertiles)
p value
1 2 3
Number 51 50 51
Sex (M:F) 27:24 26:24 27:25 0.994*
Birth weight (kg) 2.705 ± 0.316 3.314 ± 0.147 4.006 ± 0.402 0.000
Birth weight range (kg) 2.15-3.15 3.18-3.50 3.53-5.40
Age (year) 12.94 ± 0.93 13.34 ± 0.87 13.27 ± 0.87 0.057
Weight (kg) 48.84 ± 11.01 54.18 ± 9.86 58.56 ± 12.76 0.000
Height (cm) 156.55 ± 7.52 160.28 ± 6.31 161.75 ± 7.72 0.001
BMI (kg/m
2) 19.86 ± 3.88 21.01 ± 3.17 22.28 ± 4.09 0.006
WC (cm) 69.02 ± 8.65 71.03 ± 7.26 73.57 ± 10.00 0.033
Body fat percent (%) 15.32 ± 10.30 17.91 ± 9.04 20.60 ± 11.07 0.035
Tanner stage 3.39 ± 0.57 3.58 ± 0.57 3.84 ± 0.70 0.001
SBP (mmHg) 115.55 ± 13.86 116.34 ± 12.02 115.08 ± 12.42 0.175
DBP (mmHg) 74.51 ± 9.17 74.12 ± 9.98 72.33 ± 10.47 0.016
Total cholesterol (mmol/L) 4.443 ± 0.661 4.351 ± 0.649 4.363 ± 0.794 0.909
Triglyceride (mmol/L) 0.883 ± 0.345 0.863 ± 0.353 0.853 ± 0.292 0.321
HDL-C (mmol/L) 1.247 ± 0.149 1.218 ± 0.257 1.162 ± 0.243 0.646
LDL-C (mmol/L) 2.790 ± 0.626 2.739 ± 0.518 2.809 ± 0.666 0.704
FPG (mmol/L) 5.45 ± 0.46 5.28 ± 0.50 5.36 ± 0.50 0.510
Insulin (pmol/L) 57.26 ± 35.25 51.70 ± 36.09 45.86 ± 29.42 0.012
C-peptide ( g/L) μ 1.92 ± 0.54 1.88 ± 0.56 1.87 ± 0.56 0.008
HOMA-IR 1.96 ± 1.22 1.72 ± 1.32 1.52 ± 1.00 0.012
HOMA-β 87.36 ± 71.38 86.46 ± 69.78 74.48 ± 56.73 0.143
Values are mean ± SD.
*Analyzed by chi-square test.
Adjusted for age, sex, height, weight, waist circumference, body fat percent, and Tanner stage.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C,
HDL-cholesterol, LDL-C, LDL-cholesterol; FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment for insulin
resistance; HOMA- , homeostasis model assessment for -cell function. β βThe Relation between Birth Weight and Insulin Resistance in Korean Adolescents
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birth weight and physiological characteristics in
adolescents, except for HDL-cholesterol (r = -0.167;
p = 0.040). However, each physiologic variable in
adolescents correlated with current anthropome-
tric parameters. Thus, we performed partial cor-
relation analyses to examine the relationship
between each physiological characteristic while
controlling for the effects of current anthropo-
metric parameters. After adjustment for gender,
current age, height, weight, waist circumference,
body fat percentage, and Tanner stage, birth
weight was inversely related to diastolic blood
pressure (r = -0.184; p = 0.029), insulin (r = -0.194; p
= 0.021), C-peptide (r = -0.237; p = 0.004), and
HOMA-IR (r = -0.195; p = 0.020). But, the relation-
ship between birth weight and HDL-cholesterol
was attenuated (r = -0.071; p = 0.403) (Table 3).
DISCUSSION
After an epidemiological study showing the
increased risk of developing T2DM in adults who
were under-weight at birth, the hypothesis was
proposed that insulin resistance syndrome and
metabolic syndrome are closely related to fetal
nutritional state. In a study on residents of the
Hertfordshire and Preston areas in England, Hales
et al.
3 reported that the weight at birth and 1 year
correlate inversely to the development of diabetes
in adults. The risk of diabetes is decreased as birth
weight is increased. Thus, they argued that mal-
nutrition during the fetal and neonatal period
impairs the formation of the endocrinal pancreas,
resulting in the impairment of insulin secretion by
beta cells. Hales et al. proposed the thrifty
phenotype hypothesis as a causality of T2DM.
2 In
addition, they reported that in 5,654 men who
were underweight at birth and 2 years after birth,
the death rate due to ischemic cardiac diseases
was high,
4 and in subsequent studies, they ob-
served that blood pressure and plasma fibrinogen
were increased in adults who had had low body
weight compared to placenta weight.
12,13 Such
reports argue that maternal malnutrition during
important periods for the fetus may cause per-
manent structural and functional changes in
specific organs such as the liver, blood vessels,
pancreatic tissues, etc., and that the time of mal-
nutrition and specific characteristics may deter-
Table 3. Association of Birth Weight with Physiological Characteristics in Adolescents
Pearson’s correlation After adjustment*
r p value r p value
SBP (mmHg) -0.020 0.810 -0.118 0.161
DBP (mmHg) -0.095 0.243 -0.184 0.028
Total cholesterol (mmol/L) -0.104 0.203 -0.065 0.443
Triglyceride (mmol/L) -0.069 0.395 -0.089 0.292
HDL-C (mmol/L) -0.167 0.040 -0.054 0.527
LDL-C (mmol/L) -0.042 0.605 -0.034 0.684
FPG (mmol/L) -0.008 0.918 -0.039 0.643
Insulin (pmol/L) -0.142 0.083 -0.175 0.037
C-peptide ( g/L) μ -0.113 0.168 -0.224 0.005
HOMA-IR -0.150 0.066 -0.180 0.032
HOMA-β -0.088 0.283 -0.103 0.222
*Adjusted for age, sex, height, weight, waist circumference, body fat percent, and Tanner stage. BMI, body mass index; WC, waist
circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, HDL-cholesterol, LDL-C, LDL-cholesterol; FPG,
fasting plasma glucose; HOMA-IR, Homeostasis model assessment for insulin resistance; HOMA- , Homeostasis model assessment for β
-cell function. βChul-Sik Kim, et al.
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mine the pattern of metabolic impairment such as
diabetes, hypertension, dyslipidemia, etc. They
proposed that impairment of the initial formation
of beta cells in the pancreas may be an important
factor for the development of T2DM. In other
words, if the fetus is exposed to nutrition defici-
ency or malnutrition during the active prolifera-
tion of beta cells, the developing fetus undergoes
metabolic adaptation.
14 The developmental dys-
genesis of endocrinal pancreas is induced during
such processes and cannot completely recover by
the intake of sufficient nutrition. Under such
conditions, insulin secretion remains impaired,
and in adults requiring increased amounts of
insulin, diabetes may develop.
In most studies on birth weight and insulin
resistance, low birth weight infants show in-
creased insulin resistance as adolescences or
adults.
5 Similar results were obtained in a study
of Koreans
6 that investigated the relationships
between birth weight and insulin secretion,
resistance, and various anthropometric indices in-
cluding visceral fat area in healthy young males.
They found a positive association between birth
weight and insulin sensitivity in adult life.
However, there were some limitations in their
study. First, the subjects were not randomly
selected, and the study did not include both sexes.
In addition, although they found a positive rela-
tionship between birth weight and insulin sensi-
tivity in adulthood, they omitted the interaction
between current insulin sensitivity and current
body size.
The hypothesis that an adult disease has fetal
origins is plausible, but much supporting evi-
dence is flawed by incomplete and incorrect statis-
tical interpretation.
15 Some observational studies
show a direct association between low birth
weight and current adult health status.
12,16-19
However, in other studies this relationship has
emerged only after body size at some later period
(notably current weight or body mass index) has
been adjusted for.
20-25 Adjusting for current size
has been justified on the grounds that birth
weight or size is positively related to later size,
and also that current weight or fatness is posi-
tively related to the outcome variable of interest
(for example, LDL-cholesterol). If not adjusted for
current weight or fatness, the relationship be-
tween birth weight and the outcome variable
could be obscured.
26
In our study, each physiologic variable (blood
pressure, lipid profiles, HOMA index) in adoles-
cence correlated with current anthropometric
parameters (data not shown). Thus, we performed
partial correlation analyses to examine the rela-
tionship between each physiological characteristic
in adolescence while controlling for the effects of
current anthropometric parameters. Therefore,
low birth weight was related to insulin resistance
in adolescence; insulin, C-peptide, and HOMA-IR
were higher in the lower birth weight tertile.
Meanwhile, birth weight correlated negatively to
insulin, C-peptide, and HOMA-IR.
The finding of a non-significant difference in
fasting plasma glucose levels among the birth
weight tertiles for males and females was some-
what unexpected. However, there were some dif-
ferences in the patterns of the child-adult rela-
tionship; in children, the relationships reported
were inconsistent: absent, positive or U-shaped.
17,27,28 In the natural progression of T2DM, relative
insulin resistance and high insulin secretion are
followed by elevated plasma glucose. So in the
earlier stages of T2DM, insulin resistance and, as
a result, high insulin secretion may be predo-
minant.
5
In our study, birth weight was not significantly
related to systolic blood pressure. However, we
detected a small but significant negative cor-
relation between birth weight and diastolic blood
pressure. The majority of studies that have
examined the relationship between birth weight
and blood pressure in adolescents reported an
inverse relationship,
29 but it was often smaller
than that reported in prepubescent children and
adults. In a longitudinal study of Finnish children
and adolescents,
30 it was found that during
puberty, the inverse relationship between birth
weight and blood pressure is smaller, but is
restored to previous levels after puberty. This
change in the association of birth weight and
blood pressure may be due to the perturbed
tracking of blood pressure during the adolescent
growth phase.
29 There was no direct association
between birth weight and lipid profiles in ado-
lescents in our study, and this result is consistent
with previous systematic reviews.
31,32The Relation between Birth Weight and Insulin Resistance in Korean Adolescents
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There are a number of possible limitations in
our study. Some of the birth weight data were
reported by participants' parents. However, vali-
dity of parent-reported birth weight has been pre-
viously confirmed.
20,25,33 This cohort has not been
followed-up between birth and adolescence, so we
can not show the growth patterns during infancy,
which are known to be an important determinant
of later insulin resistance.
34 In addition, genetic
influence cannot be entirely eliminated, although
subjects with family history of diabetes (diabetes
in either parent) were excluded from the study.
Hattersley et al.
35 suggested that insulin-regulated
fetal growth, and hence birth weight, are deter-
mined by fetal insulin secretion and insulin
action, which are in turn regulated by fetal
genotype. Dunger et al.
36 showed an association
between common genetic variation at a variable
number of tandem repeat (VNTR) loci in the
promoter region of the insulin gene and birth size.
Moreover, it remains possible that birth weight is
not the marker at birth most strongly related to
insulin resistance.
In conclusion, low birth weight was related to
insulin resistance in Korean adolescents and ade-
quate gestational nutrition is necessary to prevent
low birth weight.
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